Related Experiment Video
Updated: Jul 8, 2025

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Published on: February 9, 2021
Enzyme-Activatable Near-Infrared Photosensitizer with High Enrichment in Tumor Cells Based on a Multi-Effect Design
Yuyao Li1,2, Chaoying Zhang1, Qingyi Wu1
1State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Abstract:
Enzyme-activatable near-infrared (NIR) fluorescent probes and photosensitizers (PSs) have emerged as promising tools for molecular imaging and photodynamic therapy (PDT). However, in living organisms selective retention or even enrichment of these reagents after enzymatic activation at or near sites of interest remains a challenging task. Herein, we integrate non-covalent and covalent retention approaches to introduce a novel "1-to-3" multi-effect strategy-one enzymatic stimulus leads to three types of effects-for the design of an enzyme-activatable NIR probe or PS. Using this strategy, we have constructed an alkaline phosphatase (ALP)-activatable NIR fluorogenic probe and a NIR PS, which proved to be selectively activated by ALP to switch on NIR fluorescence or photosensitizing ability, respectively. Additionally, these reagents showed significant enrichment (over 2000-fold) in ALP-overexpressed tumor cells compared to the culture medium, accompanied by massive depletion of intracellular thiols, the major antioxidants in cells. The investigation of this ALP-activatable NIR PS in an in vivo PDT model resulted in complete suppression of HeLa tumors and full recovery of all tested mice. Encouragingly, even a single administration of this NIR PS was sufficient to completely suppress tumors in mice, demonstrating the high potential of this strategy in biomedical applications.
Insights
This study introduces a novel strategy for enzyme-activatable near-infrared (NIR) probes and photosensitizers (PSs). The approach enhances tumor cell retention and shows promise for effective photodynamic therapy (PDT) in cancer treatment.
Area of Science:
- Biomedical Engineering
- Molecular Imaging
- Photodynamic Therapy
Background:
- Enzyme-activatable near-infrared (NIR) probes and photosensitizers (PSs) are valuable for molecular imaging and photodynamic therapy (PDT).
- Selective retention of these activated reagents at target sites in vivo remains a significant challenge.
Purpose of the Study:
- To develop a novel "1-to-3" multi-effect strategy for enzyme-activatable NIR probes and PSs.
- To create an alkaline phosphatase (ALP)-activatable NIR probe and PS with enhanced tumor cell enrichment and therapeutic efficacy.
Main Methods:
- Integration of non-covalent and covalent retention approaches for reagent design.
- Construction of an ALP-activatable NIR fluorogenic probe and a NIR PS.
- Evaluation of probe/PS activation, cell enrichment, and in vivo efficacy in a tumor model.
Main Results:
- Selective activation of NIR fluorescence and photosensitizing ability by ALP.
- Over 2000-fold enrichment of reagents in ALP-overexpressed tumor cells.
- Complete suppression of HeLa tumors in vivo with a single administration of the NIR PS, leading to full mouse recovery.
Conclusions:
- The developed "1-to-3" multi-effect strategy enables enzyme-activatable NIR probes and PSs with superior retention and therapeutic potential.
- This approach demonstrates high efficacy in preclinical photodynamic therapy, offering a promising avenue for cancer treatment.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016